report
7.7 Review

This report was peer reviewed by experts with a significant experience in the fields of Nanotechnology, medicine, biology, and materials. The experts are

Prof. Dr. Alex Dommann

CTO

CSEM Centre Suisse d'Electronique et de Microtechnique SA

Switzerland

Prof. Dr. Hans-Jörg Fecht

Chaired Professor and Director "Institute of Micro and Nanomaterials" at Ulm University and Senior Scientist "Nanostructured Materials", Institute for Nanotechnology INT, Forschungszentrum Karlsruhe

Germany

Prof. Dr. Hans Hoffmeister

CEO

Zellwerk GmbH

Germany

Prof. Dr. Roland Lauster

Head of Medical Biotechnology

Technical University of Berlin

Germany

Document details:

Visits: 4882, Published on: May, 14th 2009, 10:27 AM, Last edit: 2009-06-02 12:57:26 Size: 686 Byte

Related documents:

Showing 0-10 of 12 results « Previous Page: 1 2Next »

Order by

Fig. 1: Nanomaterials and nanostructures classified by their reduced dimensions Fig. 1: Nanomaterials and nanostructures classified by their reduced...	Show document info	68 KByte
Fig. 2: Sectorial breakdown of nanomedicine patent filings worldwide Fig. 2: Sectorial breakdown of nanomedicine patent filings worldwide (EPODOC database,...	Show document info	32 KByte
Fig. 6: Net revenues for Vitoss® Fig. 6: Net revenues for Vitoss®; Source: Orthovita, Inc., Annual report,...	Show document info	45 KByte
Fig. 6: Net revenues for Vitoss®. Source: Orthovita, Inc., Annual report, 2007 Fig. 6: Net revenues for Vitoss®. Source: Orthovita, Inc., Annual report,...	Show document info	45 KByte
Fig. 2: Sectorial breakdown of nanomedicine patent filings worldwide (EPODOC database, 1993–2003) Fig. 2: Sectorial breakdown of nanomedicine patent filings worldwide (EPODOC database,...	Show document info	32 KByte
Fig. 1: Nanomaterials and nanostructures classified by their reduced dimensions Fig. 1: Nanomaterials and nanostructures classified by their reduced...	Show document info	68 KByte
Fig. 5: Revenue by product for 2007 from Orthovita. Vitoss® is a nanostructured bone replacement material. Source: Orthovita, Inc., Annual report, 2007 Fig. 5: Revenue by product for 2007 from Orthovita. Vitoss® is a nanostructured bone replacement material. Source: Orthovita, Inc., Annual report,...	Show document info	26 KByte
Fig. 3: Application of Ostim in dental bone grafting; ©Heraeus Kulzer GmbH Fig. 3: Application of Ostim in dental bone grafting; ©Heraeus Kulzer...	Show document info	18 KByte
Fig. 3: Application of Ostim in dental bone grafting; ©Heraeus Kulzer GmbH Fig. 3: Application of Ostim in dental bone grafting; ©Heraeus Kulzer...	Show document info	18 KByte
Fig. 3: Application of Ostim in dental bone grafting; ©Heraeus Kulzer GmbH Fig. 3: Application of Ostim in dental bone grafting; ©Heraeus Kulzer...	Show document info	16 KByte

Showing 0-10 of 12 results « Previous Page: 1 2Next »

Order by

Jump back to top

report7.7 Review

Document details:

Related documents:

report
7.7 Review